Save your place

Sign in to WhoBought

Please try again later.

Arcutis Biotherapeutics, Inc. (ARQT) institutional ownership

Latest close $27.35 Jul 24, 2026
Market cap$3.1B 52-week range SectorHealthcare
Funds holding · Q1 2026
269
reported ARQT position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
137 buyers · 132 sellers

Arcutis Biotherapeutics, Inc. (ARQT) price and institutional activity

Dates

Q1 2026

$0 bought by 137 investors
Marshall Wace, LLPState Street +135 more
$0 sold by 132 investors
Jennison Associates LLCT. Rowe Price Associates +130 more
Bought Sold Totals per quarter; hover a bar for the names.

Arcutis Biotherapeutics, Inc. (ARQT) institutional activity · 269

Investor Type Est. change Change Δ Own Date
Marshall Wace, LLP · Added
Change +2.0M Date Q1 2026
Marshall Wace, LLP Added· Q1 2026 +2.0M Q1 2026
Jennison Associates LLC · Reduced
Change −1.8M Date Q1 2026
Jennison Associates LLC Reduced· Q1 2026 −1.8M Q1 2026
State Street · Added
Change +808K Date Q1 2026
State Street Added· Q1 2026 +808K Q1 2026
T. Rowe Price Associates · Reduced
Change −718K Date Q1 2026
T. Rowe Price Associates Reduced· Q1 2026 −718K Q1 2026
Ensign Peak Advisors, Inc · Reduced
Change −658K Date Q1 2026
Ensign Peak Advisors, Inc Reduced· Q1 2026 −658K Q1 2026
Squarepoint Ops LLC · Added
Change +648K Date Q1 2026
Squarepoint Ops LLC Added· Q1 2026 +648K Q1 2026
Bamco Inc · Added
Change +567K Date Q1 2026
Bamco Inc Added· Q1 2026 +567K Q1 2026
Oberweis Asset Management Inc/ · Added
Change +558K Date Q1 2026
Oberweis Asset Management Inc/ Added· Q1 2026 +558K Q1 2026
Bank of America Corp · Added
Change +548K Date Q1 2026
Bank of America Corp Added· Q1 2026 +548K Q1 2026
Deutsche Bank AG · Reduced
Change −540K Date Q1 2026
Deutsche Bank AG Reduced· Q1 2026 −540K Q1 2026
Vanguard · Added
Change +497K Date Q1 2026
Vanguard Added· Q1 2026 +497K Q1 2026
Nuveen, LLC · Reduced
Change −480K Date Q1 2026
Nuveen, LLC Reduced· Q1 2026 −480K Q1 2026
M&g PLC · New
Change +469K Date Q1 2026
M&g PLC New· Q1 2026 +469K Q1 2026
Jump Financial, LLC · Reduced
Change −381K Date Q1 2026
Jump Financial, LLC Reduced· Q1 2026 −381K Q1 2026
Manufacturers Life Insurance Company, the · Added
Change +378K Date Q1 2026
Manufacturers Life Insurance Company, the Added· Q1 2026 +378K Q1 2026
Data through Q1 2026 · filed Jun 3, 2026
15 of 269

Famous investor activity in Arcutis Biotherapeutics, Inc. (ARQT)

Arcutis Biotherapeutics, Inc. (ARQT) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Peetz Christopher · Director 3 operations 39K
Owned 13K Trade date Jul 15, 2026 Filed date Jul 17, 2026
Peetz Christopher Director 3 operations 39K 13K Jul 15, 2026 Jul 17, 2026
Welgus Howard G. · Director Sell −$127K
Price $26.91 Qty −5K Owned 37K ΔOwn −11.3% Trade date Jul 15, 2026 Filed date Jul 17, 2026
Welgus Howard G. Director Sell $26.91 −5K −$127K 37K −11.3% Jul 15, 2026 Jul 17, 2026
Welgus Howard G. · Director 6 operations 0
Price $6.52–$8.63 Owned 23K Trade date Jul 15, 2026 Filed date Jul 17, 2026
Welgus Howard G. Director 6 operations $6.52–$8.63 0 23K Jul 15, 2026 Jul 17, 2026
Welgus Howard G. · Director Sell −$16K
Price $25.67 Qty −635 Owned 38K Trade date Jun 17, 2026 Filed date Jun 17, 2026
Welgus Howard G. Director Sell $25.67 −635 −$16K 38K Jun 17, 2026 Jun 17, 2026
Lin Sue-Jean · Director Sell −$121K
Price $24.38 Qty −5K Owned 28K Trade date Jun 15, 2026 Filed date Jun 17, 2026
Lin Sue-Jean Director Sell $24.38 −5K −$121K 28K Jun 15, 2026 Jun 17, 2026
Welgus Howard G. · Director Sell −$100K
Price $24.41 Qty −4K Owned 38K Trade date Jun 15, 2026 Filed date Jun 17, 2026
Welgus Howard G. Director Sell $24.41 −4K −$100K 38K Jun 15, 2026 Jun 17, 2026
Welgus Howard G. · Director 6 operations 0
Price $6.52–$8.63 Owned 25K Trade date Jun 15, 2026 Filed date Jun 17, 2026
Welgus Howard G. Director 6 operations $6.52–$8.63 0 25K Jun 15, 2026 Jun 17, 2026
Heron Patrick J. · Director 2 operations 22K
Owned 17K Trade date Jun 5, 2026 Filed date Jun 9, 2026
Heron Patrick J. Director 2 operations 22K 17K Jun 5, 2026 Jun 9, 2026
Lin Sue-Jean · Director 2 operations 22K
Owned 17K Trade date Jun 5, 2026 Filed date Jun 9, 2026
Lin Sue-Jean Director 2 operations 22K 17K Jun 5, 2026 Jun 9, 2026
Welgus Howard G. · Director 2 operations 22K
Owned 17K Trade date Jun 5, 2026 Filed date Jun 9, 2026
Welgus Howard G. Director 2 operations 22K 17K Jun 5, 2026 Jun 9, 2026
Leonard Keith R. · Director 2 operations 22K
Owned 17K Trade date Jun 5, 2026 Filed date Jun 9, 2026
Leonard Keith R. Director 2 operations 22K 17K Jun 5, 2026 Jun 9, 2026
Curran Terrie · Director 2 operations 22K
Owned 17K Trade date Jun 5, 2026 Filed date Jun 9, 2026
Curran Terrie Director 2 operations 22K 17K Jun 5, 2026 Jun 9, 2026
Munshi Amit · Director 2 operations 22K
Owned 17K Trade date Jun 5, 2026 Filed date Jun 9, 2026
Munshi Amit Director 2 operations 22K 17K Jun 5, 2026 Jun 9, 2026
Gilbert Halley E. · Director 2 operations 22K
Owned 17K Trade date Jun 5, 2026 Filed date Jun 9, 2026
Gilbert Halley E. Director 2 operations 22K 17K Jun 5, 2026 Jun 9, 2026
Krishnamohan Neha · Director 2 operations 22K
Owned 17K Trade date Jun 5, 2026 Filed date Jun 9, 2026
Krishnamohan Neha Director 2 operations 22K 17K Jun 5, 2026 Jun 9, 2026
15 of 91
15 of 91 Sign in to continue to older insider transactions.

Arcutis Biotherapeutics, Inc. (ARQT) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
FMR LLC 9.1M
% of shares outstanding 15.0% Filing date Feb 9, 2023
FMR LLC 9.1M 15.0% Feb 9, 2023
Jennison Associates LLC 12.1M
% of shares outstanding 10.8% Filing date Mar 6, 2024
Jennison Associates LLC 12.1M 10.8% Mar 6, 2024
Suvretta Capital Management, LLC 9.5M
% of shares outstanding 10.0% Filing date Feb 13, 2024
Suvretta Capital Management, LLC 9.5M 10.0% Feb 13, 2024
Suvretta Capital Management, LLC 9.6M
% of shares outstanding 10.0% Filing date Oct 30, 2023
Suvretta Capital Management, LLC 9.6M 10.0% Oct 30, 2023
Rubric Capital Management LP 11.0M
% of shares outstanding 9.4% Filing date Nov 13, 2024
Rubric Capital Management LP 11.0M 9.4% Nov 13, 2024
Frazier Life Sciences Viii, L.P. 8.8M
% of shares outstanding 9.3% Filing date Oct 26, 2023
Frazier Life Sciences Viii, L.P. 8.8M 9.3% Oct 26, 2023
Frazier Life Sciences Viii, L.P. 8.8M
% of shares outstanding 7.8% Filing date Mar 6, 2024
Frazier Life Sciences Viii, L.P. 8.8M 7.8% Mar 6, 2024
Blackrock, Inc. 9.0M
% of shares outstanding 7.7% Filing date Nov 8, 2024
Blackrock, Inc. 9.0M 7.7% Nov 8, 2024
8 of 19

Arcutis Biotherapeutics, Inc. (ARQT) ownership FAQ

Who owns ARQT?

269 reporting institutions disclosed ARQT position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.